Open Demat Account
Become a
New
Partner
Financial
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
PMS
TraderX
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
Alternative Investment Funds
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Indian - Formulations
Share
Syncom Formulations (India) Ltd Share Price
Pharmaceuticals - Indian - Formulations
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
14.92
14.92
Date :
Dec 12,2025 EOD
-0.03
(-0.20)
-0.13
(-0.02)
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
14.95
Buy (size)
0.00(x0)
Sell (size)
14.92(×27)
Buy Qty
0
Sell Qty
27
Today's High
(₹)
15.04
Today's Low
(₹)
14.79
52 Week High
(₹)
23.49
52 Week Low
(₹)
14.10
Market Statistics
Div Yield (%)
0
EPS
0.67
Book Value
4.03
Market Cap
1402.48
Face Value
1
Market Lot
1
AGM Date
Sep
Closure Date
Sep
ISIN No
INE312C01025
Share Holding Pattern
Total Foreign (Promoter & Group)
0
Indian (Promoter & Group)
475347599
Total of Promoter
475347599
Non Promoter (Institution)
936228
Non Promoter (Non-Institution)
463716173
Total Non Promoter
464652401
Total Promoter & Non Promoter
940000000
Custodians(Against Depository Receipts)
0
Grand Total
940000000
News
Syncom Formulations (India) Ltd
Syncom Formulations (India) consolidated net ..
13-Nov-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) consolidated net profit rises 49.41% in the September 2025 quarter
Net profit of Syncom Formulations (India) rose 49.41% to Rs 16.60 crore in the quarter ended September 2025 as against Rs 11.11 crore during the previous quarter ended September 2024. Sales rose 18.97% to Rs 121.72 crore in the quarter ended September 2025 as against Rs 102.31 crore during the previous quarter ended September 2024.
Particulars
Quarter Ended
Sep. 2025
Sep. 2024
% Var.
Sales
121.72
102.31
19
OPM %
15.12
11.89
-
PBDT
23.39
16.15
45
PBT
22.04
14.85
48
NP
16.60
11.11
49
Syncom Formulations (India) Ltd
Syncom Formulations (India) announces board m..
08-Nov-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) announces board meeting date
Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 November 2025.
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Shareholder..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Shareholder Meeting / Postal Ballot-Scrutinizers Report
Submission of Results for the 37th Annual general meeting held on 29th Sep 2025
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Shareholder..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 37th Annual General meeting held on 29th Sep 2025
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcemen..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Change in Management_Appointment of Chairman and Secreterial Auditor as confirmed in the 37th Annual general Meeting
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcemen..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Alteration in MOA and AOA as approved in the 37th AGM
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcemen..
01-Oct-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Secretarial Auditor confirmed in 37th AGM
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Syncom Form..
24-Sep-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Syncom Formulations (India) Limited - Trading Window
Syncom Formulations (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Closure of ..
23-Sep-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Closure of Trading Window
NOTICE OF TRADING WINDOW CLOSURE IN THE SHARES OF THE COMPANY FOR THE QUARTER AND HALF YEAR ENDED 30.09.2025
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcemen..
02-Sep-2025
Read More
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of newspaper clippings of Notice of 37th Annual General Meeting.
Corporate Details
Board of Directors
Incorporation Year
1988
Chairman
ANKIT KEDARMAL BANKDA
Auditor
Sanjay Mehta & Associates
Face Value
1
Market Lot
1
Listing
BSE,NSE,
Registered Office
207 Saket Nagar Near Saket Club  MP Madhya Pradesh Indore452001
Contact
Telephone: 91-22-30887744
Fax: 91-22-30887755
Chairman & Exec. Director
Kedarmal Bankda
ED / MD / Promoter
Vijay Bankda
Independent Non Exe. Director
Ruchi Jindal
Ritesh Kumar Lunkad
Ankit Jain
Chairman / Executive Director / WTD
ANKIT KEDARMAL BANKDA
Company Sec. & Compli. Officer
Vaishali Agrawal
Mutual Fund Holdings
1-2
of 2
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
Motilal Oswal BSE Healthcare ETF
0.02
0.05
38.10
Bandhan BSE Healthcare Index Fund
0.01
0.05
18.09
FAQ
What is the share price of Syncom Formulations (India) Ltd today on NSE and BSE?
The Syncom Formulations (India) Ltd Share price on NSE is Rs.14.92 and BSE Rs.14.92 as on today
How to buy Syncom Formulations (India) Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Syncom Formulations (India) Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Syncom Formulations (India) Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Syncom Formulations (India) Ltd is 1402.48
What are the key financial ratios to analyse Syncom Formulations (India) Ltd Share Price?
Syncom Formulations (India) Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 22.27
ROE ratio: 15.6
Debt to Equity ratio: 0.12
EPS: 0.67
When did Syncom Formulations (India) Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Syncom Formulations (India) Ltd issued bonus shares last in 2013
What is the 52 week highest and lowest share price value of Syncom Formulations (India) Ltd?
The highest share price value is Rs. 23.49 and Lowest share price value is Rs. 14.10 for 52 week period for Syncom Formulations (India) Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Syncom Formulations (India) Ltd?
Motilal Oswal BSE Healthcare ETF has the highest amount invested with Syncom Formulations (India) Ltd.
Which year Syncom Formulations (India) Ltd was incorporated?
Syncom Formulations (India) Ltd was incorporated in 1988
What is the stock symbol of Syncom Formulations (India) Ltd?
The stock symbol for Syncom Formulations (India) Ltd shares is SYNCOMFORMULATIONS(INDIA)LTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
ABL Bio-Technologies Ltd
526955
Not Listed
ACE Laboratories Ltd
526077
ACELAB
Adline Chem Lab Ltd
524604
Not Listed
Aesculapius Remedies Ltd (Wound-up)
531786
Not Listed
Ahlcon Parenterals (India) Ltd
524448
Not Listed
Ajanta Pharma Ltd
532331
AJANTPHARM
Alps Laboratories Ltd
526003
Not Listed
American Remedies Ltd (Merged)
531534
Not Listed
Amrutanjan Health Care Ltd
590006
AMRUTANJAN
Ankur Drugs & Pharma Ltd
531683
ANKURDRUGS
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
12 Dec 2025
10,71,384.00
6,45,341.00
60.23
11 Dec 2025
9,44,563.00
5,04,898.00
53.45
10 Dec 2025
9,26,408.00
4,51,303.00
48.72
09 Dec 2025
15,51,119.00
7,73,481.00
49.87
08 Dec 2025
17,37,644.00
11,06,777.00
63.69
05 Dec 2025
12,62,546.00
8,54,919.00
67.71
04 Dec 2025
9,79,887.00
5,49,365.00
56.06
03 Dec 2025
9,85,783.00
4,89,645.00
49.67
02 Dec 2025
9,45,891.00
5,13,106.00
54.25
01 Dec 2025
11,08,874.00
5,74,585.00
51.82
28 Nov 2025
6,57,396.00
3,97,359.00
60.44
27 Nov 2025
6,73,381.00
4,39,078.00
65.20
26 Nov 2025
8,68,164.00
5,45,937.00
62.88
25 Nov 2025
11,56,005.00
5,74,088.00
49.66
24 Nov 2025
13,73,819.00
8,86,555.00
64.53
21 Nov 2025
10,55,476.00
7,23,063.00
68.51
20 Nov 2025
11,92,073.00
8,51,718.00
71.45
19 Nov 2025
11,40,408.00
6,79,344.00
59.57
18 Nov 2025
9,14,849.00
5,90,684.00
64.57
17 Nov 2025
11,78,181.00
6,64,429.00
56.39
Please wait ...